Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5759_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
93 Мб
Скачать
Chapter 41 Fetal Hydrops 1427
A B
FIGURE 41-4. Hydrocele. A, Ultrasound, and B, MRI, appearances of male fetus with hydrops with fluid extending into the scrotum.
A
FIGURE 41-5. Massive ascites leading to lung com-
pression. Coronal T2-weighted MR image shows massive
ascites (A) surrounding the liver (L) and bowel (B). Note the compression of the fetal lungs (arrows).
L
B
mediastinal shift, obstructing venous return and leading to hydrops. In large, bilateral pleural effusions the lungs appear as free-floating “bat wings” beside the heart (Fig. 41-6, D). When chronic, large effusions can lead to pulmonary hypoplasia. As pleural effusions enlarge,
compression or kinking of mediastinal vascular struc­tures causes upper body edema and functional esopha­geal obstruction, leading to secondary polyhydramnios.
Chylothorax is the most common cause of pleural effusion leading to respiratory distress in the newborn. This is an important diagnosis to suggest when associ­ated with hydrops because drainage can be curative. Drainage of the effusion can lead to reversal of hydrops and can prevent pulmonary hypoplasia. Drainage imme­diately before delivery can assist in peripartum care. When drained, the fluid has a large number of lympho­cytes in clear, yellow fluid. The fluid will not be “milky” until after the infant feeds.
Pericardial Effusions
In contrast to pleural effusions that surround the lungs and compress the tissue medially, pericardial effusions are anteromedial fluid collections. Fluid collections of up to 2 mm in thickness are common, and a small amount of pericardial fluid (up to 7 mm, in isolation) can be a normal finding8 (Fig. 41-8; Video 41-3). A large peri­cardial effusion compresses the lungs against the poste­rior chest wall (Fig. 41-9). The heart is visualized as “floating” within the anterior thoracic fluid collection.
Subcutaneous Edema
Subcutaneous edema may be localized or generalized, depending on the etiology. A thickness of 5 mm has been suggested as the cutoff value.9 Edema is most easily seen over the fetal scalp or face, where thickening of skin overlying bone is visualized (Fig. 41-10, A). It is impor­tant to realize that the biparietal diameter and head
1428 PART IV Obstetric Sonography
R
L
A B C
D E F
FIGURE 41-6. Fetal pleural effusions. A, Unilateral small right pleural effusions. B, Moderate right (R) and small left (L) effu-
sions. C, Moderate right effusion. Note moderate mediastinal shift to the left. D, Bilateral moderate effusions. Note how the partially compressed lungs appear as free-floating “bat wings.” E, Axial, and F, oblique, coronal views of large right pleural effusion. Note the severe mediastinal shift in E.
FIGURE 41-7. Small pleural effusion in association with congenital cystic adenomatoid malformation.
Note the large cystic mass (calipers) and small pleural effusion (arrow).
Chapter 41 Fetal Hydrops 1429
A B
FIGURE 41-8. Normal finding of small amount of pericardial fluid. A and B, Note the small rim of anechoic fluid
(arrows) in two different fetuses.
FIGURE 41-9. Large pericardial effusion. Lungs are
compressed posteriorly.
circumference measurements are taken around the skull bone, excluding the skin. Subcutaneous edema may also be seen over the limbs and abdominal wall. Care should be taken not to mistake prominent fat in a macrosomic fetus to anasarca in a hydropic fetus. Subcutaneous edema will increase the abdominal cir­cumference measurement, beyond that which is expected for gestational age (Fig. 41-10, B). It is important when measuring the fetus to include the entirety of the skin in the abdominal circumference measurement, because this
affects the weight calculation of the fetus. Thus, when performing biometric assessment of the hydropic fetus, the abdominal circumference measurement is included in the weight calculation, but it should be excluded from the gestational age assessment so that the thickened skin does not falsely elevate fetal age. When generalized subcutaneous edema is present, the appearances may be referred to as anasarca (Fig. 41-11, Video 41-4). Note that on fetal magnetic resonance imaging (MRI), body wall edema will appear of high signal intensity on T2-weighted images, similar to surrounding fluid (Fig. 41-12).
Placentomegaly
Placental edema is a variable and usually late sign in hydrops (Fig. 41-13). The sonographic texture of the placenta may be altered, and its appearance may be described as thickened, echogenic, spongy, or ground glass. Placental dimensions, especially thickness, are increased above the normal of 5 cm in the third trimes-
9-11
When placental edema is secondary to an hydropic
ter. process in the fetus, the entire placenta is usually affected. This finding may be used to exclude the very rare primary placental causes of hydrops (e.g., chorioangioma).
Polyhydramnios
The assessment of amniotic fluid is described in Chapter
46. Polyhydramnios occurs frequently in conjunction with hydrops (Fig. 41-14; see Video 41-1). This increases the risk of prematurity, which adds to the morbidity associated with hydrops.
1430 PART IV Obstetric Sonography
A B
FIGURE 41-10. Scalp and body wall edema are measured differently. A, Fetal scalp edema. Head measurements
(cursors) are obtained around the bone, not the skin; BPD, biparietal diameter; HC, head circumference. B, Abdominal wall thickening. Abdominal wall measurements are obtained around the abdomen, including the skin thickening; AC, abdominal circumference. Note that gestational age is 27 weeks by HC, but 34 weeks if only AC is used.
A B C
D E F
FIGURE 41-11. Anasarca in fetus with Turner’s syndrome. A, Axial view of cystic hygroma behind the neck. B, Coronal
view of diffuse scalp edema and cystic hygroma. C, Axial view of thoracic wall edema. D and E, Axial views of abdomen show body wall edema and ascites. F, Arm with anasarca as well.
ETIOLOGY
and size of fluid collections and edema as detected by
ultrasound may provide a clue to the etiology of hydrops. Before the availability of Rh0(D) immune globulin (RhoGAM), immune hydrops represented greater than 80% of all cases of hydrops. Now, nonimmune hydrops represents 90% of cases. The distribution, timing,
For example, in immune hydrops, ascites appears first,
with subcutaneous edema appearing only with more
advanced anemia. Intrathoracic collections generally do
not occur or occur late in the process.
Chapter 41 Fetal Hydrops 1431
A B
FIGURE 41-12. Fetal body wall edema on MRI. A and B, Axial and sagittal T2-weighted MR images show how edema appears
as high signal in the skin.
FIGURE 41-13. Placental edema. Placental thickness is
normally about 1 mm of thickness per week gestational age, and it should not exceed 5 cm in the third trimester.
Generally, pleural and pericardial effusions appear earlier and more prominently with thoracic pathologies, whereas ascites appears earlier and predominates with anemia and primary abdominal pathologies. Massive ascites with associated bowel hyperechogenicity is typical of either parvovirus infection (when the ascites is very tense) or a bowel perforation that may be secondary to meconium peritonitis (Fig. 41-15). Localized fluid col- lections may progress to hydrops because of pressure or metabolic effects, and thus the pattern of hydrops may evolve over time.
FIGURE 41-14. Polyhydramnios. A 12-cm pocket of fluid
(cursors) in pregnancy with hydrops.
IMMUNE HYDROPS
Immune hydrops, or erythroblastosis fetalis, occurs when a sensitized mother develops antibodies to fetal RBCs that lead to hemolysis. Circulating maternal immunoglobulin G (IgG) antibodies cross the placenta and attack antigen-positive fetal RBCs. The majority of cases still occur in the presence of Rh(D) anti­bodies. Atypical antibodies such as Kell, Rh(C), and Rh(E) develop in 1% to 2% of individuals after blood
1432 PART IV Obstetric Sonography
A
FIGURE 41-15. Meconium peritonitis. A, Matted and dilated echogenic bowel with ascites, typical of meconium peritonitis.
B, Tense ascites in meconium peritonitis.
A
FIGURE 41-16. Immune hydrops. A, Ascites (arrow). B, Middle cerebral artery measuring peak systolic velocity (PSV); EDV, end
diastolic velocity; RI, resistive index.
B
B
transfusion and cause 2% of hemolytic disease of the fetus. The result is anemia, extramedullary erythropoie­sis, hepatosplenomegaly, hypoalbuminemia, and conges­tive heart failure (CHF). Hydrops develops when the fetal hemoglobin (HbF) deficit
exceeds 7 g/dL,12 prob­ably because of reduced oncotic pressure secondary to hypoalbuminemia, combined with high-output cardiac failure (Fig. 41-16). Eventually, the fetus develops both metabolic and lactic acidosis,
13,14
and once this decom­pensation occurs, progression of hydrops is rapid, leading to fetal demise within 24 to 48 hours.
Causes of maternal sensitivity include fetal maternal hemorrhage and transplacental hemorrhage. In women with incompatible blood types with respect to the fetus (Rh alloimmunization, other RBC antigen), antibodies can be made. This typically occurs after delivery of the
first pregnancy and therefore will affect the second preg­nancy. Other times of blood sharing include abortion (spontaneous or therapeutic), amniocentesis, placental abruption, incompatible blood transfusions, and trans­placental hemorrhage. An additional blood incompati­bility issue is fetal alloimmune thrombocytopenia.
To avoid maternal sensitization, 300 mg of RhoGAM is given at 28 weeks’ gestation in sensitized individuals. This protects against 30 mL of fetal blood. If a greater degree of fetomaternal hemorrhage is suspected, a Klei­hauer-Betke test can be done to quantify fetal blood in maternal circulation to determine the necessary dose. As a prophylactic measure, RhoGAM is given to Rh­negative women within 48 hours after invasive fetal procedures such as amniocentesis and chorionic villus sampling.
Chapter 41 Fetal Hydrops 1433
Management of the Fetus
Immune hydrops is an indication for urgent fetal blood sampling and transfusion. This technique is performed
by percutaneous ultrasound-guided blood sampling (PUBS)
15
(see Chapter 46). In a study of 80 fetuses with hydrops secondary to anemia, when hydrops was mild before treatment (only a thin rim of ascites, with or without pericardial effusion), hydrops was reversed in 88%; when hydrops was severe before treatment, hydrops reversed in only 65%. This stresses the importance of early treatment in cases of suspected anemia. After rever­sal of hydrops, survival rate was 98%. loss rate after this procedure is about 1.4%.
16
The incremental
17
Noninvasive Assessment of Alloimmunization
Fetuses are screened for risk of alloimmunization by determining the Rh status of the parents. If the pregnant woman is Rh negative, the father is screened. If the father of the baby is also Rh negative, no further screening is needed. If the mother is Rh negative and the father is Rh positive, maternal antibody titers are monitored. If they rise above 1:8, further testing is warranted. In the past, this was done with amniocentesis assessing for optical density (OD
) of amniotic fluid (hemolysis
50
increases OD of amniotic fluid), and serial PUBS was performed as indicated to determine hematocrit (Hct). Currently, Hct is indirectly inferred from middle cere-
bral artery (MCA) Doppler studies, in which peak sys­tolic velocity (PSV) is elevated in cases of anemia (Video 41-5; see Chapter 43).
In response to severe anemia, the fetal circulation
becomes hyperdynamic with increased blood flow
velocities, which are thought to result from increased cardiac output and decreased viscosity of fetal blood. In addition, blood flow in the MCA may be increased further because the brain circulation is known to respond quickly to hypoxemia.
18
Although flow velocities in all fetal vessels will be increased, the MCA is particularly suitable for assessment because of its easy visualization with color Doppler imaging as it courses directly above the greater wing of the sphenoid bone, carrying more than 80% of cerebral blood flow. The MCA has a high­impedance circulation with continuous forward flow. The method for MCA Doppler includes finding the circle of Willis, measuring a pulsed Doppler waveform of the proximal MCA at the base of the brain, and obtaining a PSV measurement with the angle of insonation close to 0 degrees (Fig. 41-16, B). Intraob­server and interobserver variability is low.
In hypoxia, there is central redistribution of blood flow with increased blood flow to the brain. This leads to elevated PSV in cases of anemia. PSV is compared to normed measures with respect to gestational age. Using these thresholds, Zimmerman et al.19 found that overall
sensitivity to detect moderate to severe anemia at less than 35 weeks (hemoglobin <0.65 multiples of median) was 88%. Specificity was 87%; positive predictive value (PPV) was 53%, and negative predictive value (NPV) was 98%.
It should be recognized that immune hydrops, even untreated, is not uniformly lethal, and that transfusion is not uniformly lifesaving. If fetuses with anemia and hydrops are untreated, 34% of hydrops cases resolve spontaneously, and 30% of fetuses die in utero. However, if anemia is treated with intrauterine infusions, 53% of hydrops cases resolve and 17.5% of fetuses die in utero.
When performing PUBS, it is important to check that the mean corpuscular volume (MCV) is greater than 100 µm3 to prove that it is fetal blood being tested. The hematocrit is checked to determine the amount of trans­fusion needed (Hct <30% is 2.5th centile >20 weeks). To limit the amount of fluid being transfused into the relatively small circulatory capacity of the fetus, packed RBCs (type O negative; Hct >90%) are given. The goal is to transfuse to Hct of 40 mL/dL. Successful treatment of anemia with intravascular blood transfusion has been reported as early as 13 weeks’ gestation.
20
A variable sign of anemia in the fetus is that of hepa- tosplenomegaly. The fetal liver and spleen increase in size because of their increased production of RBCs. However, the fetus may be able to compensate for the breakdown of RBCs and, in such cases, may have a large liver and spleen, but would not necessarily be severely anemic. Conversely, more rapid breakdown of RBCs may prevent the fetus from adapting to hemolysis. Therefore, anemia may develop without hepatosplenomegaly.
21,22
NONIMMUNE HYDROPS
Nonimmune hydrops occurs in 1:1500 to 1:4000 preg­nancies. It is a common pathologic finding in first- and second-trimester spontaneous abortions. The etiology varies geographically and with gestational age. In North America and Europe, most cases are cardiovascular (20%­40%), infective (5%-10%), or chromosomal (16%; usually Turner’s syndrome; trisomy 13, 18, and 21; trip­loidy) in origin. gous α-thalassemia is a common cause; carrier status for α-thalassemia occurs in 5% to 15% of the population. Nonimmune hydrops in homozygous α-thalassemia accounts for 25% of perinatal deaths in Southeast Asia.
Pathophysiology
Nonimmune hydrops represents the terminal stage for many conditions and is frequently multifactorial (Table 41-1). Pathophysiology of hydrops may involve increased hydrostatic pressure, high-output cardiac failure, decreased plasma oncotic pressure, increased capillary permeability, obstruction of lymph flow, or a
23,24
In Southeast Asia, however, homozy-
25
in this region,
1434 PART IV Obstetric Sonography
TABLE 41-1. NONIMMUNE HYDROPS: COMMON CAUSES AND ASSOCIATIONS
EXAMPLES SUBCATEGORY EXAMPLES
Cardiovascular Structural heart disease Hypoplastic left or right heart syndrome
Myocarditis/cardiomyopathy Valvular disease Myocardial or pericardial tumors Tuberous sclerosis (e.g., rhabdomyoma) Premature closure of foramen ovale or ductus arteriosus Twin-twin transfusion syndrome Arrhythmia Tachyarrhythmia
High-output cardiac failure Tumors such as maternal chorioangioma or fetal
Generalized arterial calcification
Lymphatics Abnormal lymphatic drainage Neck Cystic hygroma
Chest Chylothorax/hydrothorax
Gastrointestinal Hepatic cirrhosis/fibrosis
Urinary tract Finnish nephrosis
Chromosomal 45,XO (Turner’s syndrome)
Hematologic
Infection Cytomegalovirus
Monochorionic twins Twin-twin transfusion syndrome (donor or recipient)
Myocardial infarction Anomalous left coronary artery
Congenital high airway obstruction
Congenital cystic adenomatoid malformation Congenital diaphragmatic hernia Pulmonary sequestration Bronchogenic cyst Congenital lymphedema
Hepatitis Tumor Portal vein thrombosis Bowel atresia Volvulus Malrotation with midgut volvulus Meconium peritonitis
Urinary tract obstruction Prune belly syndrome Cloacal malformation Renal vein thrombosis
Trisomy 21 Trisomy 18 Trisomy 13 Other aneuploidies α-Thalassemia (homozygous) Parvovirus G6PD deficiency Twin-twin transfusion (donor) Congenital leukemia Hemochromatosis Inferior vena cava thrombosis
Parvovirus Toxoplasmosis Syphilis Coxsackievirus Adenovirus Herpes simplex virus Varicella
Acardiac twin (donor)
Atrioventricular canal Atrioventricular septal defect Transposition of great vessels Tetralogy of Fallot Ebstein anomaly
Bradyarrhythmia (including heart block)
sacrococcygeal teratoma Vein of Galen malformation Acardiac twin (donor)
Chapter 41 Fetal Hydrops 1435
TABLE 41-1. NONIMMUNE HYDROPS: COMMON CAUSES AND ASSOCIATIONS—cont’d
EXAMPLES SUBCATEGORY EXAMPLES
Genetic Metabolic disorders Gaucher disease
Skeletal dysplasias Achondroplasia
Achondrogenesis Osteogenesis imperfecta Osteochondrodystrophy Osteochondrodysplasia Hypophosphatasia Thanatophoric dysplasia Asphyxiating thoracic dystrophy Short-rib polydactyly syndrome
Fetal hypokinesis Arthrogryposis
Congenital myotonic dystrophy Neu-Laxova syndrome Pena-Shokeir syndrome
Other syndromes Noonan syndrome
Cornelia de Lange syndrome Orofaciodigital syndrome Idiopathic recurrent hydrops
Tumors Wilms’ tumor
Sacrococcygeal teratoma Nephroblastoma Neuroblastoma Teratoma Tuberous sclerosis Arteriovenous malformation
Maternal Severe diabetes mellitus
Severe anemia Severe hypoproteinemia Indomethacin use (premature closure of ductus arteriosus)
Placental/cord Placental or umbilical vein thrombosis
Cord torsion, knot, or tumor Umbilical artery aneurysm Angiomyxoma of umbilical cord Hemorrhagic endovasculitis of placenta Chorioangioma
GM1 gangliosidosis Sialidosis Niemann-Pick disease types A and C Mucopolysaccharidosis Carnitine deficiency Pyruvate kinase deficiency Glucose phosphate isomerase deficiency
combination of these factors (Fig. 41-17). Fluid collec­tions result from redistribution of fetal body fluids among the intravascular, intracellular, and interstitial compartments, secondary to an imbalance in capillary ultrafiltration and interstitial fluid return.
26
Hypoxia and circulatory failure may result in capillary damage that leads to plasma protein and fluid loss from the intravas­cular compartment.
Several factors predispose to edema in the fetus versus after birth. Both total body and extracellular fluid compartments are proportionately greater in the fetus, particularly at earlier gestational ages. Colloid osmotic pressure is lower because of lower albumin concentra­tions. High compliance of the interstitial space facilitates the accumulation of large volumes of fluid. Many causes of fetal hydrops, especially those with a cardiac compo­nent, result from an increase in systemic venous pressure, to which the fetus is particularly sensitive. In the fetus,
AnemiaArrhythmia
Cardiac failure
Systemic
venous pressure
Venous or lymphatic
obstruction
Tissue hypoxia and
capillary leakage
HypoproteinemiaHydrops
FIGURE 41-17. Pathogenesis of hydrops.
Infection
Hepatocellular
damage
1436 PART IV Obstetric Sonography
there is a net movement of fluid from the intravascular to the extravascular space. Fivefold larger volumes of fluid are removed by the lymphatics in fetal models than in adult animal models. Thus, small elevations in sys­temic venous pressure (2-3 mm Hg) in the fetus can substantially reduce lymphatic flow and can drive large amounts of fluid into the extracellular space. This process is further enhanced by the relatively greater permeability of fetal capillaries to protein. The fetus is therefore par­ticularly susceptible to small elevations in venous pres­sure from a number of causes, all of which can result in hydrops.
12,13,24
Causes and Associations
Nonimmune hydrops is most commonly of a fetal etiol­ogy, but also may be caused by maternal or placental factors (Table 41-1). Maternal causes (such as poorly controlled diabetes mellitus) are rare and should be dif­ferentiated from maternal complications, which are sec­ondary to fetal hydrops (termed mirror syndrome because edema develops in the mother of an hydropic fetus, “mirroring” the condition in the fetus).
27,28
Mater­nal thyrotoxicosis can cause fetal hyperthyroidism and fetal hydrops, with potential for resolution of hydrops after treatment with antithyroid drugs.
29
Placental causes, such as chorioangioma and other vascular shunts, are relatively rare and are usually associated with high-output failure states and, in some cases, fetal anemia.
30,31
Fetal metabolic causes are rare but impor­tant, because diagnosis can lead to appropriate neonatal treatment and appropriate counseling of the patients regarding recurrence risks.
A classification scheme for fetal causes is shown in Table 41-1 and has some overlap in the groupings, some of which may represent associations rather than causations.
Cardiovascular Abnormalities
Cardiovascular abnormalities are the etiology of hydrops in up to 40% of cases.
25,32
Hydrops is a rare complication
of isolated cardiac abnormality because the fetus has a parallel flow circulation. In chromosomal abnormalities, however, other factors with or without cardiac abnor­mality lead to hydrops. Structural Cardiac Anomalies. In hydrops, cardiac structural abnormalities may be causative or may be found as associations
33
(Fig. 41-18). Right-sided lesions, whether obstructive, such as pulmonary or tricuspid atresia, or structural lesions that result in right atrial volume or pressure overload, such as mitral regurgita- tion, can result in congestive heart failure and hydrops.
34,35
Left-sided obstructive lesions, such as aortic stenosis, mitral stenosis, and coarctation of the aorta, can result in a hypoplastic left heart, causing increased blood flow through the fetal right ventricle, which may result in
FIGURE 41-18. Hydrops secondary to structural
cardiac abnormality. Note the enlarged abnormal heart,
pleural effusions, and skin thickening.
hydrops.36 The presence of hydrops with congenital structural heart disease carries a poor prognosis, with survival as low as 17% for those with tricuspid disease and hydrops.
37
Some fetuses with structural cardiac anomalies also have rhythm disturbances, which contrib­ute to the poor prognosis. In one series of 301 fetuses with atrioventricular (A-V) septal defects, the presence of fetal hydrops, together with bradycardia from sinus node dysfunction or complete heart block, was associ­ated with a poor outcome. Cardiac Tumors. Cardiac tumors are a rare cause of fetal hydrops.
39-44
Hydrops may be caused by several
38
mechanisms, depending on the tumor location, size, and number. Cardiac lesions may cause obstruction to blood flow and alteration of A-V valve function and may lead to arrhythmia, cardiac tamponade, pericardial effusion, and hydrops.
41-43
Rhabdomyomas are the most common fetal cardiac tumor and are seen in association with tuberous sclerosis in more than 80% of cases.
44
Rhabdomyomas are also the most common cardiac tumors to cause hydrops. Usually, these tumors are multiple, well circumscribed, hyperechoic, and homogeneous and mainly involve the ventricular myocardium
42
(Fig. 41-19). Rhabdomyomas tend to grow during the second half of pregnancy, most are diagnosed during the second and third trimes­ters. The location, size, and number of lesions corre­spond to risk for hydrops. Rhabdomyomas may cause hydrops as a result of impaired diastolic filling, altered A-V valve function, or outflow obstruction.
Intrapericardial teratomas are rare, usually appear­ing as cystic and solid masses outside the cardiac cavities, arising from the pericardium. Teratomas may be larger than the heart, and rapid growth of the tumor within
45
so